Depression and Anxiety Trial, Recruiting NCT06110897 Sponsor: University of Wisconsin, Madison Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06110897
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Major Depressive Disorder (a form of clinical depression) confirmed through a structured interview process
  • People who are currently experiencing at least mild depression symptoms, as measured by a standard depression rating scale
  • People between the ages of 18 and 65
  • People who are either not currently taking any mental health medications or receiving any mental health treatment, OR who have been on a stable mental health medication or treatment plan for the past 8 weeks and plan to continue that same plan throughout the study
  • People who are considered safe to exercise, either based on answers to screening questions about physical activity or with a doctor's approval
  • People who are willing to be randomly assigned to either group in the study
  • People who own a smartphone

Who may not be able to join:

  • People who are currently pregnant, breastfeeding, or planning to become pregnant during the trial
  • People with a high level of obesity classified as Class III or above (confirm with trial site for exact definition)
  • People who have ever been diagnosed with, or are currently diagnosed with, Psychosis, Mania, or Bipolar Disorder
  • People who are currently diagnosed with a Substance Use Disorder
  • People who are currently having thoughts of suicide with a specific plan and intention to act on them, requiring immediate emergency care
  • People whose behaviour, such as aggression or moderate difficulties with thinking and memory, would significantly interfere with taking part in the study, as determined by the research team
  • People who are already meeting the recommended amount of resistance exercise (at least 2 days per week) and have been doing so for the past 8 weeks
  • People who have had a concussion or traumatic brain injury within the last 3 months
  • People who have heart disease, uncontrolled high blood pressure, or uncontrolled diabetes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jacob Meyer, PhD, University of Wisconsin, Madison

Phone: 608-890-0154

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 November 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in depressive symptom severity measured by GRID Hamilton Depression Rating Scale (GRID-HAM-D); Change in self-reported depression symptom severity measured by Quick Inventory of Depressive Symptoms (QIDS); Cerebral mean blood velocity; Cerebral blood velocity pulsatility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov